Showing results (1-10 of 89) with videos related to
Sort By:
Pageof 9
Clinical Toxicology (Philadelphia, Pa.)|May 29, 2025
Characterizing pharmacobezoar formation: a descriptive analysis from VigiBaseMassimo Carollo, Nicoletta Luxi, Salvatore CrisafulliJAMA Network Open|July 9, 2024
Agreement of Different Drug-Drug Interaction Checkers for Proton Pump InhibitorsMassimo Carollo, Salvatore Crisafulli, Margherita Selleri, et al.Expert Opinion on Drug Metabolism & Toxicology|February 22, 2024
Exploring the level of agreement among different drug-drug interaction checkers: a comparative study on direct oral anticoagulantsMassimo Carollo, Salvatore Crisafulli, Francesco Ciccimarra, et al.International Journal of Molecular Sciences|June 2, 2021
Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic InertiaGuido Gembillo, Ylenia Ingrasciotta, Salvatore Crisafulli, et al.CNS Drugs|January 11, 2024
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the FutureSalvatore Crisafulli, Brigida Boccanegra, Massimo Carollo, et al.BMC Family Practice|October 20, 2021
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trialsSalvatore Crisafulli, Nicoletta Luxi, Raffaele Coppini, et al.Drugs & Aging|April 8, 2026
Prescribing Cascades: An Umbrella Review and Updated Systematic ReviewMassimo Carollo, Salvatore Crisafulli, Marta Zerio, et al.Drug Safety|February 15, 2023
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting SystemSalvatore Crisafulli, Paola Maria Cutroneo, Nicoletta Luxi, et al.Age and Ageing|April 12, 2026
Evaluating the impact of medication review and deprescribing on prescribing appropriateness and clinical outcomes in older people residing in long-term care facilities: a systematic review and meta-analysisMassimo Carollo, Irene Cristini, Salvatore Crisafulli, et al.Recenti Progressi in Medicina|July 19, 2022
[The role of real-world evidence for the study of rare diseases epidemiology and the post-marketing evaluation of orphan drugs.]Salvatore Crisafulli, Gianluca TrifiròPageof 9